14 Patents
- US125401792026Compositions and Methods for Treating Cancer with Anti-ror1 Immunotherapy
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
0 cites - US124537802025Monoclonal Antibodies Specific for Fibroblast Growth Factor Receptor 4 (FGFR4) and Methods of Their Use
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
0 cites - US123917402025Compositions and Methods for Treating Cancer with Anti-bcma Immunotherapy
LENTIGEN TECHNOLOGY, Inc.
0 cites - US123919582025Compositions and Methods for Treating Cancer with Anti-cd38 Immunotherapy
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services
0 cites - US123783212025ADAM17 Binding Molecules and Uses Thereof0 cites
- US120374032024Compositions and Methods for Treating Cancer with Anti-cd123 Immunotherapy
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services
0 cites - US119705282024Compositions and Methods for Treating Cancer with Anti-mesothelin Immunotherapy
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services
0 cites - US119393772024Affinity Matured Cd22-specific Monoclonal Antibody and Uses Thereof
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
0 cites - US118780522024Compositions and Methods for Treating Cancer with Anti-cd22 Immunotherapy
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services
0 cites - 0 cites
- US118144402023Glypican 2 as a Cancer Marker and Therapeutic Target
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
0 cites - US117084082023Compositions and Methods for Treating Cancer with Anti-cd19 Immunotherapy
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services
0 cites - US116800932023Monoclonal Antibodies That Specifically Bind to Matrilin 3 and Their Use
THE UNITED STATES OF AMERICA, As Represented By The Secretary, Department Of Health And Human Services
0 cites - US115901692023Compositions and Methods for Treating Cancer with Anti-cd123 Immunotherapy
LENTIGEN TECHNOLOGY, Inc.
0 cites